New scan study aims to Fine-Tune prostate cancer care

This study is testing whether a type of advanced scan called PSMA-PET can be used to monitor how well treatment is working for men with metastatic prostate cancer that responds to hormone therapy. Twenty participants will receive standard treatment and undergo two of these scans—one before starting and one after six months—to see if the scan results match other signs of disease status. The goal is to gather information that could help doctors better tailor future treatment plans based on scan results.